Wild-type p53 gene-induced morphological changes and growth suppression in hepatoma cells
- PMID: 9213246
- DOI: 10.1007/BF02934489
Wild-type p53 gene-induced morphological changes and growth suppression in hepatoma cells
Abstract
The human hepatocellular carcinoma (HCC) cell line, HLF, expresses only mutant-type p53 (mt-p53), which has an amino acid substitution at the 244th residue from glycine to alanine. HLF cells were transfected with wild-type p53 (wt-p53) cDNA construct pC53-SN3, mt-p53 cDNA construct pC53-SCX [which differs by a single nucleotide, resulting in alanine instead of valine at the 143rd residue in p53 (p53-143)], or pCMV-Neo-Bam, as a control, by a liposome method. After G418 selection, three wt-p53 stable transformants (WT), four mt-p53 transformants (MT), and three control vector transformants (VT) were obtained. We analyzed the cell growth and morphological changes of these transformants under different culture conditions [fetal calf serum (FCS), 10%, 1%, and 0%]. Whereas no difference from control in the growth rate and morphology was observed under the 10% FCS conditions, serum starvation induced remarkable phenotypical changes in all three WTs, but not in the other transformant. Corresponding to these phenotypical changes, the transcriptional activity of wt-p53 was increased more than nine fold. These results indicated that serum starvation would induce wt-p53 biological function, which is tightly linked to morphological changes and growth suppression. To induce these changes, the introduction of the wt-p53 gene itself was not sufficient, and additional triggering, i.e., serum starvation, was indispensable.
Similar articles
-
[The effect of p53 gene on p-glycoprotein expression and chemotherapeutic cytotoxicity of hepatocellular carcinoma].Zhonghua Gan Zang Bing Za Zhi. 2001 Aug;9(4):237-9. Zhonghua Gan Zang Bing Za Zhi. 2001. PMID: 11602059 Chinese.
-
Wild type p53 increased chemosensitivity of drug-resistant human hepatocellular carcinoma Bel7402/5-FU cells.Acta Pharmacol Sin. 2004 Jan;25(1):76-82. Acta Pharmacol Sin. 2004. PMID: 14704126
-
p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells.Oncogene. 1993 Feb;8(2):487-90. Oncogene. 1993. PMID: 8381223
-
[Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma].Zhonghua Yi Xue Za Zhi. 2003 Oct 25;83(20):1795-800. Zhonghua Yi Xue Za Zhi. 2003. PMID: 14642087 Chinese.
-
P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):341-55. doi: 10.1016/0360-3016(95)02023-3. Int J Radiat Oncol Biol Phys. 1996. PMID: 8567335 Review.
Cited by
-
Sorafenib suppresses the cell cycle and induces the apoptosis of hepatocellular carcinoma cell lines in serum-free media.Exp Ther Med. 2010 Sep;1(5):863-866. doi: 10.3892/etm.2010.131. Epub 2010 Jul 21. Exp Ther Med. 2010. PMID: 22993610 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous